Overview

Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery

Status:
Unknown status

Trial end date:
2011-11-01

Target enrollment:

Participant gender:

Summary

General and specific objectives of the search: evaluate the effects of the administration of Antithrombin III (ATIII) on the activation of the coagulation system and of the fibrinolysis, platelet function, inflammatory response and markers of organ damage in patients undergoing cardiac surgery by cardiopulmonary bypass (CPB) with low plasma levels of post-operative Antithrombin (AT).

Phase:

Phase 4

Details

Lead Sponsor:

University of Bari

Treatments:

Antithrombin III
Antithrombins